Rapid Increase in End-use Adoption to Boost Sepsis Diagnostics Market Revenue Growth | Biomerieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc

Industry Insights
The Global Sepsis Diagnostics Market was valued at USD 369.56 million in 2016 and is projected to reach USD 802.74 million by 2027, growing at a CAGR of 8.79% from 2017 to 2027. Rising prevalence of sepsis has led to a growing need for its early diagnosis. Septic poisoning may result in severe inflammation, leading to prolonged hospitalization. This condition is also one of the leading causes of death. Hence, in order to reduce the alarming mortality rate amongst people developing septicemia, demand for related diagnostic products is expected to grow to a great extent in near future.

Access full report with TOC @ https://www.worldwidemarketreports.com/sample/235785

Hospital-acquired infections also significantly contribute to the growth of the market. Such infections are a result of prolonged hospital stays. The World Health Organization (WHO) estimated that the rate of ICU-acquired infections is at least 2-3 times higher in developing countries as compared to developed countries. These infections including urinary-tract and surgical site wound infections that majorly lead to severe sepsis.

Increasing number of surgical cases leading to post-operative infections cause septic shock. Post-surgical infections generally arise due to factors such as failure to sterilize the surgical site and surgical instruments. Thus, diagnostic instruments and assays are increasingly demanded by hospitals for early detection of septic shock.

Technology Insights
Microbiology held the leading market share in 2018, primarily due to the fact that it allows the quantitative detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests.
Molecular diagnostics is anticipated to showcase attractive growth over the forecast period. Factors attributed to the growth are low turnaround time and accurate results. Such molecular diagnostic methods allow reduced hospital stays and also aid in diminishing mortality rate.

Regional Insights-
In 2018, North America led the market owing to the presence of a well-established healthcare infrastructure as well as the rapid adoption of advanced products. Moreover, septic poisoning is a leading cause of mortality in countries like U.S., which is accelerating the demand for diagnostic products.

Asia Pacific is projected to exhibit lucrative CAGR over the forecast period. This region provides immense opportunities for key players through the introduction of novel sepsis diagnostic tests to reduce the increasing mortality rate.

Sepsis Diagnostics Market Share Insights
Some of the Market Key Players are Biomerieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.), Cepheid Inc., T2 Biosystems Inc., Beckman Coulter Inc. (A Subsidiary of Danaher Corporation), Nanosphere Inc. (A Luminex Company), Bruker Corporation

To get this report at a profitable rate, Click Here-https://www.worldwidemarketreports.com/quiry/235785

About Us:
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S

Worldwide Market Reports highly customized solution allow you to make the most fruitful use of your research budget by offering you the option to purchase just the specific data you need. Extract individual sections, tables, charts or graphs from our comprehensive collection of over 800,000 market research reports sourced from over 200 publishers across nearly 700 industry sectors.

This release was published on openPR.